These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2610822)

  • 1. Characterization of the inducible serotonin-sensitive dihydroalprenolol binding sites with low affinity for isoproterenol.
    Gillespie DD; Manier DH; Sulser F
    Neuropsychopharmacology; 1989 Dec; 2(4):265-71. PubMed ID: 2610822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):201-10. PubMed ID: 2546050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain.
    Stockmeier CA; Kellar KJ
    Mol Pharmacol; 1989 Dec; 36(6):903-11. PubMed ID: 2557537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serotonin/norepinephrine-link in brain. II. Role of serotonin in the regulation of beta adrenoceptors in the low agonist affinity conformation.
    Gillespie DD; Manier DH; Sanders-Bush E; Sulser F
    J Pharmacol Exp Ther; 1988 Jan; 244(1):154-9. PubMed ID: 2826764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for two specific affinity states of 3H-antagonist binding to cardiac beta-adrenergic receptors and influence of Gpp(NH)p.
    Lang PH; Lemmer B
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):341-60. PubMed ID: 2993385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonergic neurons do not influence the regulation of beta adrenoceptors induced by either desipramine or isoproterenol.
    Hensler JG; Ordway GA; Gambarana C; Areso P; Frazer A
    J Pharmacol Exp Ther; 1991 Feb; 256(2):656-64. PubMed ID: 1847207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influences of isoproterenol pretreatment on cerebral cortical bindings of [3H]clonidine and [3H]dihydroalprenolol in infant and adult rats.
    Nomura Y; Yotsumoto I; Motomori-Suzaki E; Kawai M; Segawa T
    Brain Res; 1983 Sep; 285(3):381-4. PubMed ID: 6627028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of [125I]iodocyanopindolol to measure 5-hydroxytryptamine1B receptors in the brain of the rat.
    Offord SJ; Ordway GA; Frazer A
    J Pharmacol Exp Ther; 1988 Jan; 244(1):144-53. PubMed ID: 3335996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
    Sawutz DG; Sylvestre D; Homcy CJ
    J Immunol; 1985 Oct; 135(4):2713-8. PubMed ID: 2993414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in serotonin binding sites after 5,7-dihydroxytryptamine treatment in the rat spinal cord.
    Brown LM; Smith DL; Williams GM; Smith DJ
    Neurosci Lett; 1989 Jul; 102(1):103-7. PubMed ID: 2779841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual aminergic regulation of central beta adrenoceptors. Effect of "atypical" antidepressants and 5-hydroxytryptophan.
    Manier DH; Gillespie DD; Sulser F
    Neuropsychopharmacology; 1989 Jun; 2(2):89-95. PubMed ID: 2568116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of serotonergic denervation on the density and plasticity of brain muscarinic receptors in the rat.
    Alonso R; Soubrie P
    Synapse; 1991 May; 8(1):30-7. PubMed ID: 1714634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of multiple binding sites for [3H]5-hydroxytryptamine in the rat CNS.
    Blurton PA; Wood MD
    J Neurochem; 1986 May; 46(5):1392-8. PubMed ID: 3958711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
    Matsumoto I; Combs MR; Jones DJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):614-26. PubMed ID: 1738111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments.
    Hensler JG; Kovachich GB; Frazer A
    Neuropsychopharmacology; 1991 Feb; 4(2):131-44. PubMed ID: 2025379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial beta-adrenergic receptors from adrenalectomized rats: impaired formation of high-affinity agonist-receptor complexes.
    Davies AO; De Lean A; Lefkowitz RJ
    Endocrinology; 1981 Feb; 108(2):720-2. PubMed ID: 6256161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior.
    Marek GJ; Li AA; Seiden LS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):60-71. PubMed ID: 2746511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascorbate-induced lipid peroxidation and the binding of [3H]dihydroalprenolol.
    Heikkila RE
    Eur J Pharmacol; 1983 Sep; 93(1-2):79-85. PubMed ID: 6628548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
    Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.